Language:

Initial Low-Dose Gentamicin for Staphylococcus aureus Bacteremia and Endocarditis Is Nephrotoxic

Cosgrove, Sara E. ; Vigliani, Gloria A. ; Campion, Marilyn ; Fowler, Vance G. ; Abrutyn, Elias ; Corey, G. Ralph ; Levine, Donald P. ; Rupp, Mark E. ; Chambers, Henry F. ; Karchmer, Adolf W. ; Boucher, Helen W.

Clinical infectious diseases, 2009-03, Vol.48 (6), p.713-721 [Peer Reviewed Journal]

Oxford: The University of Chicago Press

Full text available

Citations Cited by

Actions
1. Add to e-Shelf
2. Remove from e-Shelf
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Initial Low-Dose Gentamicin for Staphylococcus aureus Bacteremia and Endocarditis Is Nephrotoxic
Author: Cosgrove, Sara E. ; Vigliani, Gloria A. ; Campion, Marilyn ; Fowler, Vance G. ; Abrutyn, Elias ; Corey, G. Ralph ; Levine, Donald P. ; Rupp, Mark E. ; Chambers, Henry F. ; Karchmer, Adolf W. ; Boucher, Helen W.
Subjects: Adult ; Aged ; Aged, 80 and over ; Anti-Bacterial Agents - administration & dosage ; Anti-Bacterial Agents - adverse effects ; Anti-Bacterial Agents - therapeutic use ; Articles and Commentaries ; Bacteremia ; Bacteremia - drug therapy ; Bacteria ; Bacterial diseases ; Bacterial sepsis ; Biological and medical sciences ; Cardiology. Vascular system ; Clinical trials ; Cohort Studies ; Creatinine - blood ; Cubism ; Daptomycin - therapeutic use ; Dosage ; Drug dosages ; Drug therapy ; Drug Therapy, Combination ; Endocardial and cardiac valvular diseases ; Endocarditis ; Endocarditis, Bacterial - drug therapy ; Female ; Gentamicins - administration & dosage ; Gentamicins - adverse effects ; Gentamicins - therapeutic use ; Heart ; Human bacterial diseases ; Humans ; Infectious diseases ; Kidney - drug effects ; Male ; Medical sciences ; Medications ; Metabolic Clearance Rate ; Middle Aged ; Nephrotoxicity ; Penicillin ; Penicillins - therapeutic use ; Prospective Studies ; Renal clearance ; Safety ; Staphylococcal Infections - drug therapy ; Staphylococcal infections, streptococcal infections, pneumococcal infections ; Staphylococcus aureus ; Staphylococcus aureus - drug effects ; Staphylococcus aureus - isolation & purification ; Studies ; Vancomycin - therapeutic use ; Young Adult
Is Part Of: Clinical infectious diseases, 2009-03, Vol.48 (6), p.713-721
Notes: ark:/67375/HXZ-G0HL6RFH-Q
istex:32121A0A5633D7A3AD4EFBDF337317710458C50C
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Description: Background.The safety of adding initial low-dose gentamicin to antistaphylococcal penicillins or vancomycin for treatment of suspected Staphylococcus aureus native valve endocarditis is unknown. This study evaluated the association between this practice and nephrotoxicity. Methods.We performed a prospective cohort study of safety data from a randomized, controlled trial of therapy for S. aureus bacteremia and native valve infective endocarditis involving 236 patients from 44 hospitals in 4 countries. Patients either received standard therapy (antistaphylococcal penicillin or vancomycin) plus initial low-dose gentamicin (n=116) or received daptomycin monotherapy (n=120). We measured renal adverse events and clinically significant decreased creatinine clearance in patients (1) in the original randomized study arms and (2) who received any initial low-dose gentamicin either, as a study medication or <2 days before enrollment. Results.Renal adverse events occurred in 8 (7%) of 120 daptomycin recipients, 10 (19%) of 53 vancomycin recipients, and 11 (17%) of 63 antistaphylococcal penicillin recipients. Decreased creatinine clearance occurred in 9 (8%) of 113 of evaluable daptomycin recipients, 10 (22%) of 46 vancomycin recipients, and 16 (25%) of 63 antistaphylococcal penicillin recipients. An additional 21 patients received initial low-dose gentamicin <2 days before study enrollment. A total of 22% of patients who received initial low-dose gentamicin versus 8% of patients who did not receive initial low-dose gentamicin experienced decreased creatinine clearance (P=.005). Independent predictors of a clinically significant decrease in creatinine clearance were age ⩾65 years and receipt of any initial low-dose gentamicin. Conclusions.Initial low-dose gentamicin as part of therapy for S. aureus bacteremia and native valve infective endocarditis is nephrotoxic and should not be used routinely, given the minimal existing data supporting its benefit.
Publisher: Oxford: The University of Chicago Press
Language: English

Links

Back to results list

Previous Result 8 Next Go to Next page

Implemented by: Social Network Logos:

Initial Low-Dose Gentamicin for Staphylococcus aureus Bacteremia and Endocarditis Is Nephrotoxic

Cosgrove, Sara E. ; Vigliani, Gloria A. ; Campion, Marilyn ; Fowler, Vance G. ; Abrutyn, Elias ; Corey, G. Ralph ; Levine, Donald P. ; Rupp, Mark E. ; Chambers, Henry F. ; Karchmer, Adolf W. ; Boucher, Helen W.

Oxford: The University of Chicago Press

Searching Remote Databases, Please Wait